MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome. - Wikidata - wikimedia - TriplyDB

MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome.

MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome.

http://www.wikidata.org/entity/Q34253639

about

Epigenetic mechanisms involved in melanoma pathogenesis and chemoresistance Epigenetic regulation in human melanoma: past and future MGMT methylation correlates with melphalan pelvic perfusion survival in stage III melanoma patients: a pilot study.Inhibition of DNA repair with MGMT pseudosubstrates: phase I study of lomeguatrib in combination with dacarbazine in patients with advanced melanoma and other solid tumours Genetics and epigenetics of the skin meet deep sequence.Screening significantly hypermethylated genes in fetal tissues compared with maternal blood using a methylated-CpG island recovery assay-based microarray.Role of MGMT as biomarker in colorectal cancer.The promoter methylation and expression of the O6-methylguanine-DNA methyltransferase gene in uterine sarcoma and carcinosarcoma.O6-methylguanine DNA methyltransferase as a promising target for the treatment of temozolomide-resistant gliomas Chemotherapy in the management of advanced cutaneous malignant melanoma.What is the role of chemotherapy in the treatment of melanoma?The functional role of long non-coding RNAs and epigenetics.Rewiring the solid tumor epigenome for cancer therapy.Immunohistochemical analysis of O(6)-methylguanine-DNA methyltransferase in human melanoma in comparison with skin squamous cell carcinoma.Epigenetic alterations in sporadic basal cell carcinomas.MGMT promoter methylation status in Merkel cell carcinoma: in vitro versus invivo.Clinical and Prognostic Significance of O6-Methylguanine-DNA Methyltransferase Promoter Methylation in Patients with Melanoma: A Systematic Meta-Analysis.Clinical correlation of MGMT protein expression and promoter methylation in Chinese glioblastoma patients.Molecular pathology of cutaneous melanoma MGMT promoter methylation is associated with temozolomide response and prolonged progression-free survival in disseminated cutaneous melanoma

P2860

Q26778761-ACE01C23-31D1-4036-B12F-9319A62D6F24 Q28085681-95888FAE-8CA4-4CCA-8216-983F7A71765B Q30491635-E63CAAD7-5E6C-494E-BDD5-99E9BF504D2A Q33396508-E4D5A847-320F-48F2-B6DA-4887C25E786B Q33904361-7ADEF50C-3049-4A65-A7F8-8EA92AA5701F Q34308038-45A2FF58-5641-4544-A852-6E642AC5370D Q34706115-C22C3C99-8FE4-4D63-921D-DE9CB8906995 Q36225952-1A8989AD-BB57-4E81-8073-E1A4A59CD908 Q36288503-5D41E958-6A4F-4455-A4EC-15489402A840 Q37007984-63D4D633-7832-4FE7-BD28-757DF1D55D43 Q38193716-AE5AC378-D9BE-4B44-8A67-44F53D159B60 Q38256144-A8F58F2A-2F5D-4E51-B783-526911286EEA Q38895216-3E34DCB3-2966-4B4C-9BCE-8AE2B8E3FC04 Q39457448-A8FC2CE2-3DE3-4153-B4F1-F7179DCE54EA Q42454854-05BDA95A-9688-4579-B5BB-9666F8A5C68E Q51061357-DE7ABB9E-8056-476C-93B5-5306EE99AA68 Q55087346-41067C40-3F27-418D-B760-A70DA1E39F40 Q55463316-423F317B-7D09-4F8E-89B7-A55D655DAA06 Q56428911-CB1EA1E4-AEF6-4676-9C5F-A3D37D4E90B9 Q56828332-BAD230C4-6DE6-48D0-8ECD-49FFFA792704

P2860

MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome.

http://www.wikidata.org/entity/Q34253639

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

MGMT gene promoter methylation ...... but not with clinical outcome.

@ast

MGMT gene promoter methylation ...... but not with clinical outcome.

@en

MGMT gene promoter methylation ...... but not with clinical outcome.

@nl

type

label

MGMT gene promoter methylation ...... but not with clinical outcome.

@ast

MGMT gene promoter methylation ...... but not with clinical outcome.

@en

MGMT gene promoter methylation ...... but not with clinical outcome.

@nl

prefLabel

MGMT gene promoter methylation ...... but not with clinical outcome.

@ast

MGMT gene promoter methylation ...... but not with clinical outcome.

@en

MGMT gene promoter methylation ...... but not with clinical outcome.

@nl

P1433

Q34253639-0DF9BCB5-B7E6-450C-888E-64E3FCEDD080

P1476

Q34253639-AF0757AE-92EB-4787-AE34-EC267DA3E3C5

P2093

Q34253639-1365982D-D51F-4B76-9677-A456779E40F5

Q34253639-184358BB-C2EE-4833-B4D0-F9D9DC9C7347

Q34253639-19FCF5A8-4C76-4015-8F7A-B742F58D001B

Q34253639-1DC25293-BB33-4949-868A-936C6C5183EA

Q34253639-1EF13D1C-32B6-4D90-B493-08EF0273DC0E

Q34253639-42A62603-5B26-4875-878B-31A4D32EADF9

Q34253639-6D342FDB-A40F-4498-8540-1E794874AC91

Q34253639-88DE1181-CD6A-41F6-8105-BAC1832C0B40

Q34253639-8B149A42-BB0C-4776-BF15-E4BFE7A30F63

Q34253639-B9BF08A5-7C6D-4A38-A16C-9EF0F095C768

P2860

Q34253639-073446B9-5152-40CF-8383-F8FA7A65AFFD

Q34253639-0A9F6B19-1F65-44A4-A184-F0D7C6867075

Q34253639-20179FE4-13EB-4828-A4BE-8DDAA3826A26

Q34253639-2C69426B-9B8B-4FC4-8943-16FA45379473

Q34253639-3524865E-08E3-46B6-B6A0-18FD6F08A2AD

Q34253639-46438F14-A4B4-4D50-A30B-351E5AFC4330

Q34253639-4DD13C6A-FD14-46FB-8F97-97F5F230F8AD

Q34253639-50277052-67C9-470B-9AF6-2B5AC5B48553

Q34253639-53CC5CFA-A743-487B-8B7F-31694EC97EC2

Q34253639-5F5AA611-2B0E-44A1-8E9C-3A4125C03BF8

P2888

Q34253639-D5EFF36B-50D7-4B08-84B1-30ECBE24B097

P304

Q34253639-5E8C8B20-B7D9-4B2B-B6BE-2535DCDDE1F2

P31

Q34253639-3FC67207-BC87-4D6D-B4BE-9B5166DA6A48

P356

Q34253639-BA8FDB7A-F295-46C9-B3BB-773A601ECF41

P407

Q34253639-A3761839-51F4-47B1-86DF-8C13BC3A5013

P433

Q34253639-CDABD8F7-7D1D-4821-8541-1D7631E55F6F

P478

Q34253639-2BA0E3F4-8D83-4D73-9AB3-A54E1D58CDA4

P577

Q34253639-D5BBCA50-E936-48A5-815E-E2D7FCD43F09

P5875

Q34253639-51D3B30A-C448-40E3-9DF4-B7A2A3149ED9

P6179

Q34253639-A1ECC868-BB20-44EE-85E8-E7A415157DDC

P698

Q34253639-B86E7637-28F8-43C7-9B9D-2774015804FC

P932

Q34253639-8D6373BC-4182-49CE-B16E-ED8C7294F713

P356

P1433

British Journal of Cancer

P1476

MGMT gene promoter methylation ...... but not with clinical outcome.

@en

P2093

A Sucker

http://www.w3.org/2001/XMLSchema#string

C Mauch

http://www.w3.org/2001/XMLSchema#string

C Stresemann

http://www.w3.org/2001/XMLSchema#string

D Schadendorf

http://www.w3.org/2001/XMLSchema#string

H Kurzen

http://www.w3.org/2001/XMLSchema#string

I Moll

http://www.w3.org/2001/XMLSchema#string

J C Hassel

http://www.w3.org/2001/XMLSchema#string

K Rass

http://www.w3.org/2001/XMLSchema#string

K Spieth

http://www.w3.org/2001/XMLSchema#string

L Edler

http://www.w3.org/2001/XMLSchema#string

P2860

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG).

O6 alkylguanine-DNA alkyltransferase activity in human myeloid cells.

Common variants of DNA repair genes and malignant melanoma.

MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents.

COBRA: a sensitive and quantitative DNA methylation assay.

O6-methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma.

Temozolomide induces senescence but not apoptosis in human melanoma cells.

O6-methylguanine-DNA-methyltransferase expression and gene polymorphisms in relation to chemotherapeutic response in metastatic melanoma.

Management of metastatic melanoma.

P2888

P304

820-826

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6605796

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P577

2010-08-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45828169

http://www.w3.org/2001/XMLSchema#string

P6179

1001282606

http://www.w3.org/2001/XMLSchema#string

P698

20736948

http://www.w3.org/2001/XMLSchema#string

P932

2966614

http://www.w3.org/2001/XMLSchema#string